Skip to content

Local Assessment of Management of Burn Patients

Local Assessment of Management of Burn Patients (LAMiNAR) - a Prospective Observational International Multicenter Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02312869
Acronym
LAMiNAR
Enrollment
300
Registered
2014-12-09
Start date
2015-09-30
Completion date
2017-05-01
Last updated
2017-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns - Multiple, Mechanical Ventilation

Keywords

Mechanical Ventilation, Burn patients

Brief summary

In the general intensive care unit (ICU) population, there is strong evidence for benefit from lung-protective mechanical ventilation, including the use of low tidal volumes and adequate levels of positive end-expiratory pressure (PEEP). In burn patients it is highly uncertain whether these settings are beneficial and there are even concerns over safety of, in particular use of low tidal volumes. There is lack of international guidelines and consequently ventilation practice in burn patients may widely vary. The primary objective is to determine ventilation practice in burn ICUs worldwide, focusing on the size of tidal volumes and the levels of PEEP used for burn patients. In addition, data on other strategies considered important in patients who receive ventilation are also collected, including data on neuromuscular blocking agents, sedatives and analgesics, and type and amount of intravenous fluids used in the period of ventilation. The secondary objective is to determine the association between tidal volume size and levels of PEEP, and duration of ventilation in burn patients.

Detailed description

Patient population: Consecutive burn patients admitted to participating burn ICUs who receive invasive ventilation, irrespective of severity of burn injury and/or presence of inhalation trauma are eligible for participation. Data collection: includes burn patients admitted within a period of three months. Demographic and baseline data are collected from the clinical files on the day of admission. If available, standard of care and clinical outcome parameters are collected daily until day 14, death or discharge from ICU, whatever comes first. Sample size: The primary objective is to determine (variations in) ventilation practice in burn patients in burn ICUs. Therefore, the sample size is based on the main secondary objective, which is to determine the association between the following ventilator settings: tidal volume, PEEP, FiO2 and mode; and outcome of burn patients. The investigators calculated the sample size for a multiple regression model: a sample size of at least 300 patients is required to have a power of 0.80, a significance level of 0.05, using an estimated effect size of 0.04, while using 4 independent variables in the model. Ethics Approval: National coordinators will be responsible for clarifying the need for ethics approval and applying for this where appropriate according to local policy. Centres will not be permitted to record data unless ethics approval or an equivalent waiver is in place. The investigators expect that in most, if not every participating country, a patient informed consent is not be required. Monitoring: Due to the observational nature of the study, a DSMB is not necessary. Organization: National co-ordinators will lead the project within individual nations and identify participating hospitals, translate study paperwork, distribute study paperwork and ensure necessary regulatory approvals are in place. They provide assistance to the participating clinical sites in trial management, record keeping and data management. Local coordinators in each site will supervise data collection and ensure adherence to Good Clinical Practice during the trial.

Interventions

OTHERNo intervention

not applicable, observational study

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Burns * Admission to a participating burn ICU Need for invasive ventilation * Informed consent (only if applicable in the country where data are collected)

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Ventilation parametersUp to 14 days during mechanical ventilationTidal volume size; milliliters per kilogram of predicted body weight

Secondary

MeasureTime frameDescription
Number of ventilator-free days and alive at day 28From day 1 to day 28Defined as the number of days, from day 1 to day 28, the patient is alive and breathes without assistance of a mechanical ventilator, if the period of unassisted breathing lasted at least 24 consecutive hours. Notably, if after successful withdrawal of mechanical ventilation the patient requires ventilation for a surgical procedure, this will not count as a 'ventilator day'. If ventilation is prolonged after surgery due to respiratory insufficiency, the day(s) ventilation is required counts as a 'ventilator day'
Other Ventilation ParametersUp to 14 days during mechanical ventilationPeak and plateau pressures or maximum airway pressure
Length of Stay in ICU on Day 90Until day 90Time between admission and discharge or death
Length of Stay in Hospital on Day 90Until day 90Time between admission and discharge or death
All-cause ICU MortalityUntil day 90Any death during ICU stay
Need for Tracheostomydaily up to 14 days from inclusionNeed for tracheostomy, first tracheostomy will be assessed up to 14 days from inclusion
Daily Lung Injury ScoresUp to 14 days during mechanical ventilationScore based on chest X-ray findings (if obtained), PaO2/FiO2, PEEP level and respiratory compliance.
Daily Sequential Organ Failure Assessment (SOFA)-scoresDaily up to 14 days from inclusionsix-organ dysfunction/failure score measuring multiple organ failure daily
ComplicationsDaily up to 14 days from inclusionComplications will include: Skin and soft tissue infections
All-cause Hospital MortalityUntil day 90Any death during hospital stay

Other

MeasureTime frameDescription
Standard care strategiesDaily up to 14 days from inclusionStrategies considered to be important in patients who receive ventilation, including: Fluid balance, types and dose of fluids used

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026